Company / Free Cash Flow per Share
Prime Medicine, Inc. Free Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.10
FY2024
5-year range
-$4.36 / -$1.10
FY2020-FY2024
Trend
+42.7%
vs FY2023
Sector context
#101 of 191
Health Care
What the data says
At $-1.10, Prime Medicine, Inc.'s free cash flow per share ranks #101 of 191 in the Health Care sector. Improved from $-4.36 to $-1.10 over the past 2 years.
Based on SEC 10-K filings.
-1.10 in FY2024.
Improved from $-4.36 to $-1.10 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#101 of 191 in Health CareTop 53% of 191This company -$1.10 Sector average -$24.68
▼
+95.6% above sector average
Key checks
Key Insights
- In FY2024, free cash flow per share increased 42.7% year-over-year.
- Ranks #101 out of 191 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.10 | +42.7% |
| FY2023 | -$1.91 | +56.1% |
| FY2022 | -$4.36 | -48.1% |
| FY2021 | -$2.95 | -25.8% |
| FY2020 | -$2.34 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026